S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Heron Therapeutics (HRTX) News Today

$2.64
-0.07 (-2.58%)
(As of 04/19/2024 ET)
SourceHeadline
seekingalpha.com logoHeron Therapeutics: Zynrelef Potentially Eases Shareholder Pain
seekingalpha.com - April 16 at 6:27 PM
MarketBeat logoNeedham & Company LLC Reiterates "Buy" Rating for Heron Therapeutics (NASDAQ:HRTX)
americanbankingnews.com - April 13 at 6:16 AM
nasdaq.com logoCommit To Buy Heron Therapeutics At $2, Earn 22.4% Annualized Using Options
nasdaq.com - April 12 at 12:35 AM
prnewswire.com logoHeron Therapeutics to Host Investor Day on May 15, 2024 in New York City
prnewswire.com - April 11 at 4:05 PM
MarketBeat logoHeron Therapeutics (NASDAQ:HRTX) Share Price Crosses Above 200-Day Moving Average of $1.82
americanbankingnews.com - April 10 at 3:26 AM
marketbeat.com logoCongress Park Capital LLC Purchases 1,209,500 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)
marketbeat.com - April 1 at 6:28 AM
prnewswire.com logoHeron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
prnewswire.com - March 28 at 4:05 PM
marketbeat.com logoHeron Therapeutics (NASDAQ:HRTX) Shares Pass Above Two Hundred Day Moving Average of $1.67
marketbeat.com - March 21 at 3:11 AM
ca.finance.yahoo.com logoHRTX Apr 2024 1.500 call
ca.finance.yahoo.com - March 16 at 4:59 AM
finance.yahoo.com logoHeron Therapeutics Full Year 2023 Earnings: Beats Expectations
finance.yahoo.com - March 14 at 9:02 AM
marketwatch.com logoHeron Therapeutics Soars After 4Q Earnings Beat
marketwatch.com - March 14 at 12:50 AM
theglobeandmail.com logoBiotech Finds Mid-Week Success Following Q4 Earnings Release
theglobeandmail.com - March 13 at 7:49 PM
markets.businessinsider.com logoWhy Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday?
markets.businessinsider.com - March 13 at 7:49 PM
finance.yahoo.com logoQ4 2023 Heron Therapeutics Inc Earnings Call
finance.yahoo.com - March 13 at 9:49 AM
finance.yahoo.com logoHeron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 13 at 9:49 AM
marketbeat.com logoHeron Therapeutics (NASDAQ:HRTX) Given New $5.00 Price Target at Needham & Company LLC
marketbeat.com - March 13 at 8:18 AM
finance.yahoo.com logoHeron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
finance.yahoo.com - March 12 at 6:03 PM
finance.yahoo.com logoHeron Therapeutics Inc (HRTX) Exceeds Full-Year Revenue Guidance for 2023
finance.yahoo.com - March 12 at 6:03 PM
marketbeat.com logoHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Acquired by Adage Capital Partners GP L.L.C.
marketbeat.com - March 12 at 5:53 AM
msn.com logoHeron Therapeutics Q4 2023 Earnings Preview
msn.com - March 11 at 8:11 PM
markets.businessinsider.com logoWhat Wall Street expects from Heron Therapeutics's earnings
markets.businessinsider.com - March 11 at 3:10 PM
benzinga.com logoPreview: Heron Therapeutics's Earnings
benzinga.com - March 11 at 3:10 PM
marketbeat.com logoHeron Therapeutics (HRTX) to Release Quarterly Earnings on Tuesday
marketbeat.com - March 5 at 4:50 AM
finance.yahoo.com logoHeron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
finance.yahoo.com - February 28 at 10:49 AM
prnewswire.com logoHeron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
prnewswire.com - February 28 at 8:00 AM
msn.com logoHeron Therapeutics (HRTX) Price Target Increased by 18.52% to 6.80
msn.com - February 24 at 9:19 AM
benzinga.com logoHeron Therapeutics Stock (NASDAQ:HRTX), Short Interest Report
benzinga.com - February 22 at 9:16 AM
marketbeat.com logoHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by D.A. Davidson & CO.
marketbeat.com - February 17 at 6:12 AM
finance.yahoo.com logoHRTX Mar 2024 0.500 call
finance.yahoo.com - February 17 at 1:37 AM
marketbeat.com logoTejara Capital Ltd Acquires 469,548 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)
marketbeat.com - February 16 at 12:21 PM
finance.yahoo.com logoInvestors in Heron Therapeutics (NASDAQ:HRTX) from five years ago are still down 90%, even after 23% gain this past week
finance.yahoo.com - February 16 at 10:36 AM
marketbeat.com logoJW Asset Management LLC Increases Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX)
marketbeat.com - February 12 at 12:53 PM
finance.yahoo.com logoOcular Therapeutix (OCUL) Surges 12.9%: Is This an Indication of Further Gains?
finance.yahoo.com - February 12 at 8:20 AM
finance.yahoo.com logoAll You Need to Know About Heron Therapeutics (HRTX) Rating Upgrade to Strong Buy
finance.yahoo.com - February 6 at 1:46 PM
finance.yahoo.com logoHeron (HRTX) Gains 19% on FDA Nod for Zynrelef Label Expansion
finance.yahoo.com - January 25 at 8:39 AM
marketwatch.com logoHeron Therapeutics Shares Rise 15% After FDA Approves Expanded Use of Zynrelef
marketwatch.com - January 24 at 10:38 PM
markets.businessinsider.com logoHeron Therapeutics: Strong Buy on Zynrelef’s Market Expansion and Strategic Collaborations
markets.businessinsider.com - January 24 at 10:38 PM
msn.com logoPremarket Heats Up For Biotech Before Opening Bell
msn.com - January 24 at 5:34 PM
finance.yahoo.com logoHeron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod
finance.yahoo.com - January 24 at 5:34 PM
msn.com logoHeron Therapeutics rises on securing label expansion for pain therapy
msn.com - January 24 at 7:44 AM
markets.businessinsider.com logoHeron : FDA Oks ZYNRELEF Indication Expansion To Include Addl. Orthopedic & Soft Tissue Procedures
markets.businessinsider.com - January 24 at 2:43 AM
finance.yahoo.com logoHeron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
finance.yahoo.com - January 23 at 9:42 PM
finance.yahoo.com logoHeron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the company
finance.yahoo.com - January 22 at 9:57 AM
finance.yahoo.com logoHeron Therapeutics (HRTX) Just Flashed Golden Cross Signal: Do You Buy?
finance.yahoo.com - January 15 at 12:53 PM
marketwatch.com logoHeron Therapeutics Shares Rise 17% After Zynrelef Distribution Partnership
marketwatch.com - January 9 at 6:38 PM
marketbeat.com logoStockNews.com Downgrades Heron Therapeutics (NASDAQ:HRTX) to Sell
marketbeat.com - January 8 at 10:18 PM
marketbeat.com logoTraders Buy High Volume of Heron Therapeutics Call Options (NASDAQ:HRTX)
marketbeat.com - January 8 at 11:23 AM
msn.com logoHeron gains on deal to expand sales network for pain therapy Zynrelef
msn.com - January 8 at 9:52 AM
markets.businessinsider.com logoHeron Therapeutics Partners With CrossLink Life Sciences To Expand Promotional Effort For Zynrelef
markets.businessinsider.com - January 7 at 11:09 PM
finance.yahoo.com logoHeron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain
finance.yahoo.com - January 7 at 6:08 PM
Get Heron Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

HRTX Media Mentions By Week

HRTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HRTX
News Sentiment

0.66

0.52

Average
Medical
News Sentiment

HRTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HRTX Articles
This Week

2

1

HRTX Articles
Average Week

Get Heron Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:HRTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners